Risk factors: new risk-assessment guidelines-more or less personalized?

Michael J Blaha1, Roger S Blumenthal1

  • 1The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Carnegie 565A, Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD 21287, USA.

Insights

The updated cardiovascular-risk guidelines offer new equations for women and African Americans, including stroke prediction. However, they still rely on traditional factors and may limit personalized assessments for intermediate-risk individuals.

Area of Science:

  • Cardiology
  • Public Health
  • Risk Assessment

Background:

  • The American College of Cardiology/American Heart Association (ACC/AHA) released updated cardiovascular-risk assessment guidelines.
  • These guidelines aim to improve the prediction of cardiovascular events in diverse populations.

Purpose of the Study:

  • To evaluate the key changes and limitations of the new ACC/AHA cardiovascular-risk guidelines.
  • To assess the impact of updated equations on risk stratification, particularly for women and African Americans.

Main Methods:

  • Analysis of the updated ACC/AHA cardiovascular-risk guideline equations.
  • Comparison of new risk factors and prediction models with previous versions.
  • Evaluation of the implications for intermediate-risk patient groups.

Main Results:

  • The guidelines incorporate updated equations for women and distinct equations for African Americans.
  • Stroke prediction is now included in the risk assessment.
  • The equations predominantly rely on traditional risk factors and are heavily influenced by age.
  • The intermediate-risk group, crucial for personalized assessment, is potentially reduced.

Conclusions:

  • While the updated ACC/AHA guidelines offer improvements in risk prediction for specific demographics, their reliance on traditional factors and age may limit nuanced, personalized risk assessment.
  • Further research may be needed to refine risk models for intermediate-risk individuals and incorporate a broader range of risk determinants.

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
398
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
880